netFormulary NHS
Pan Mersey
Area Prescribing Committee
 Formulary Chapter 11: Eye - Full Section

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.


Review date: January 2023

Non-formulary drugs: Any drug or formulation not listed in the formulary is deemed to be non-formulary.

Off-label use: Drugs are included in the formulary for their licensed indications – where inclusion of off-label use is considered to be included in the formulary this is specifically stated in the formulary entry for the drug N.B. also see Paediatrics note below.

Paediatrics: Drugs are included in the formulary for paediatric use for their BNF for Children recommended indications (indicated by symbol View childrens BNF) which may be off-label, unless otherwise stated. All drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.

NHS England Specialised Commissioning
Drugs carrying the NHS England logo are commissioned by them. Links to key documents, national programmes of care, and clinical reference groups are found below.

NHSE NHS England Specialised Commissioning: Key documents

NHSE NHS England Specialised Commissioning: National programmes of care and clinical reference groups

11.01 Administration of drugs to the eye
11.02 Control of microbial contamination
11.03 Anti-infective eye preparations
11.03.01 Antibacterials
11.03.02 Antifungals
11.03.03 Antivirals
11.03.04 Intra-ocular anti-infective preparations
Subconjunctival injections
Intravitreal and intracameral injections
11.04 Corticosteroids and other anti-inflammatory preparations
11.04.01 Corticosteroids
Corticosteroids combined with antimicrobials
Intravitreal corticosteroids
11.04.02 Other anti-inflammatory preparations
11.05 Mydriatics and cycloplegics
11.06 Treatment of glaucoma
Prostaglandin analogues and prostamides
Combination products prostaglandin anologues with timolol
Combination products sympathomimetics plus timolol
Combination products sympathomimetic plus carbonic anhydrase inhibitors
Carbonic anhydrase inhibitors topical preparations
Combination products topical carbonic anhydrase inhibitors with timolol
Carbonic anhydrase inhibitors systemic agents
11.07 Local anaesthetics
11.08 Miscellaneous ophthalmic preparations
11.08.01 Tear deficiency, ocular lubricants, and astringents
Initial management of dry eyes in primary care
Ocular surface disease diagnosed and managed by secondary care
11.08.02 Ocular diagnostic and peri-operative preparations and photodynamic treatment
Ocular diagnostic preparations
Ocular peri-operative drugs
Subfoveal choroidal neovascularisation
Vitreomacular traction
11.10 Additional treatments used in the management of ophthalmic conditions not listed in BNF chapter 11 Miscellaneous